Global Etamsylate (Ethamsylate) Market Size By Type (Tablet, Injection), By Application (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2023 to 2032
Report Id: 32958 | Published Date: Apr 2026 | No. of Pages: | Base Year for Estimate: Apr 2026 | Format:
lobal Etamsylate (Ethamsylate) Market Report Description
The Global Etamsylate (Ethamsylate) Market was valued at USD 430 million in 2023 and is projected to reach USD 670 million by 2031, expanding at a CAGR of 5.7% during the forecast period from 2023 to 2031. Etamsylate is widely used as a hemostatic agent to prevent and control capillary bleeding across clinical, surgical, gynecological, and dental applications. The market growth is fueled by the increasing demand for anti-hemorrhagic drugs in developing healthcare sectors, rising surgical volumes globally, and growing awareness regarding rare bleeding disorders.
Drivers
1. Rising Incidence of Surgical Procedures:
With the growing global geriatric
population and higher prevalence of chronic diseases requiring surgical
intervention, the use of Etamsylate as a bleeding control agent is expanding
rapidly in clinical settings.
2. Increased Awareness of Hemostatic
Management:
Awareness initiatives and medical training
programs around hemostatic emergencies have led to higher adoption of
Etamsylate in both emergency and elective procedures, especially in emerging
healthcare markets.
3. Expanding Gynecological Applications:
Etamsylate is increasingly used in the
treatment of menorrhagia and postpartum hemorrhage, both common complications
in women's health, thus contributing significantly to market demand.
Restraints
1. Availability of Alternative Therapies:
The presence of more advanced recombinant
and plasma-derived therapies, including tranexamic acid and desmopressin, poses
a challenge to the widespread adoption of Etamsylate.
2. Limited Regulatory Approvals in North
America:
Etamsylate is not approved in countries
like the U.S. and Canada, which restricts its potential market size and limits
penetration into high-income markets with significant healthcare expenditure.
Opportunity
1. Market Penetration in Developing
Countries:
Emerging economies in Asia, Africa, and
Latin America with limited access to high-cost bleeding control agents offer
significant growth potential for Etamsylate due to its affordability and
broad-spectrum hemostatic effects.
2. Increasing Focus on Emergency and Trauma
Care:
Global investment in trauma care and
emergency preparedness, especially post-pandemic, is creating a favorable
environment for the use of rapid-onset hemostatic agents such as Etamsylate.
Market
by System Type Insights
Based on system type, the Tablet
Formulation segment accounted for the largest revenue share in 2023 due to its
non-invasive nature, cost-effectiveness, and ease of administration. However,
the Injectable Formulation segment is expected to register the fastest growth
during the forecast period owing to its rapid onset of action and expanding use
in hospital and emergency room settings.
Market
by End-use Insights
By end use, Hospitals and Clinics dominated
the market in 2023, accounting for over 60% of global revenue, owing to the
high utilization of Etamsylate in surgical and acute care settings. The
Gynecology Centers segment is expected to witness significant growth due to
increased usage in managing menstrual and obstetric bleeding.
Market
by Regional Insights
Geographically, Asia-Pacific led the market
in 2023 and is expected to continue dominating due to high population density,
increasing surgical volumes, and broader regulatory acceptance of Etamsylate.
Meanwhile, Latin America is projected to experience the fastest CAGR, driven by
public health investments and demand for affordable hemostatic agents.
Competitive
Scenario
Key players in the Global Etamsylate Market
include Ciron Drugs & Pharmaceuticals, Alchem International, Abbott
Laboratories, Omega Pharma, Cipla Ltd., and Medinova Pharmaceuticals. These
companies are focusing on regional expansion, product availability in public
health tenders, and research on new therapeutic indications.
Scope
of Work – Global Etamsylate (Ethamsylate) Market
|
Report
Metric |
Details |
|
Market Size (2023) |
USD 430 million |
|
Projected Market Size (2031) |
USD 670 million |
|
CAGR (2023–2031) |
5.7% |
|
Market Segments |
By System Type (Tablet, Injection), By
End-Use (Hospitals & Clinics, Gynecology Centers, Emergency Care) |
|
Growth Drivers |
Rising surgical volumes, expanding
gynecological applications, increasing awareness of hemostatic management |
|
Opportunities |
Penetration in emerging markets,
expansion of trauma and emergency care infrastructure |
Key
Market Developments
2023: Cipla Ltd. expanded its Etamsylate
product line in Southeast Asia, targeting post-partum hemorrhage and surgical
bleeding management.
2024: Abbott Laboratories launched a
combined formulation therapy using Etamsylate and Tranexamic Acid for advanced
hemostatic efficacy in select European markets.
2025: Omega Pharma announced a licensing
agreement for Etamsylate-based products in public healthcare programs across
Latin America.
FAQs
1) What is the current market size of the
Global Etamsylate (Ethamsylate) Market?
The market size was USD 430 million in
2023.
2) What is the major growth driver of the
Global Etamsylate (Ethamsylate) Market?
The increasing number of surgical
procedures and rising awareness of bleeding control are key growth drivers.
3) Which is the largest region during the
forecast period in the Global Etamsylate (Ethamsylate) Market?
Asia-Pacific is projected to be the largest
region throughout the forecast period.
4) Which segment accounted for the largest
market share in Global Etamsylate (Ethamsylate) Market?
Tablet Formulation accounted for the
largest market share in 2023.
5) Who are the key market players in the
Global Etamsylate (Ethamsylate) Market?
Key players include Cipla Ltd., Ciron Drugs
& Pharmaceuticals, Abbott Laboratories, Medinova Pharmaceuticals, and Omega
Pharma.
Let me know if you'd like this in DOCX or
PDF format, or if you need another report.
Speak with an analyst to get exclusive insights tailored to your needs
Related Reports
Global Venous thromboembolism(VTE)Therapeutics Market By Type (Deep Vein Thrombosis(DVT),Pulmonary E...
The Global Venous Thromboembolism (VTE) Therapeutics Market was valued at USD 1.8 billion in 2023 an...
Read More
Global Vein Illumination Device Market By Type (Transillumination, Infrared Technology, Ultrasound)...
The Global Vein Illumination Device Market was valued at USD 200 million in 2023 and is projected to...
Read More
Global Vasculitis Treatment Market By Type (Large Vasculitis Treatment, Medium Vasculitis Treatment,...
The Global Vasculitis Treatment Market was valued at USD 500 million in 2023 and is projected to rea...
Read More
Global Vascular Guidewires Market By Type (Nitinol, Stainless Steel, Hybrid), By Application (Hospi...
The Global Vascular Guidewires Market was valued at USD 1.3 billion in 2023 and is projected to reac...
Read More
Global Vagus nerve stimulation Market By Type (Implantable VNS Devices, External VNS Devices), By Ap...
The Global Vagus Nerve Stimulation (VNS) Market was valued at USD 625 million in 2023 and is projec...
Read More
Global In-line UV-Vis Spectroscopy Market By Type (Color Measurement, Chemical Concentration, Turbid...
The In-line UV-Vis Spectroscopy Market is expected to grow at a CAGR of 10.2% between 2023 and 2030,...
Read More
Global Venturi Masks Market By Type (24% Oxygen Masks, 28% Oxygen Masks, 31% Oxygen Masks, 35% Oxyge...
Between the years 2023 and 2030, it is anticipated that the Global Venturi Masks Market will experie...
Read More
Global Knee Massager Market By Type (Knee Massager,Knuckle Massager,Elbow Massager), By Application...
The growing awareness of joint health and the rising incidence of knee-related conditions like arthr...
Read More
Global Mechanical Thrombectomy Devices Market By Type (Stroke, Deep Vein Thrombosis (DVT), Pulmonary...
The Global Mechanical Thrombectomy Devices Market was valued at USD 1.3 billion in 2023 and is proje...
Read More
Global Vaginal Slings Market By Type (Biologic, Synthetic Slings), By Application (Clinics, Hospital...
The Global Vaginal Slings Market was valued at USD 1.1 billion in 2023 and is projected to reach USD...
Read More.png)